These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38438001)

  • 1. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
    Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.
    Räsänen JE; Neittaanmäki N; Ylitalo L; Hagman J; Rissanen P; Ylianttila L; Salmivuori M; Snellman E; Grönroos M
    Br J Dermatol; 2019 Aug; 181(2):265-274. PubMed ID: 30329163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
    Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
    Dirschka T; Ekanayake-Bohlig S; Dominicus R; Aschoff R; Herrera-Ceballos E; Botella-Estrada R; Hunfeld A; Kremser M; Schmitz B; Lübbert H; Puig S
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):288-297. PubMed ID: 30022544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.
    Wang P; Xie F; Zhang L; Zhao S; Zhu L; Shen S; Li D; Chen Z; Xiao R; Lu Y; Lei X; Li Y; Zhang G; Zeng W; Wang X
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103611. PubMed ID: 37211296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.
    Zhu L; Wang P; Zhang G; Zhang L; Liu X; Hu C; Yang X; Sroka R; Zhou Z; Wang X
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():366-371. PubMed ID: 30336290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined versus conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
    Sáenz-Guirado S; Cuenca-Barrales C; Vega-Castillo J; Linares-Gonzalez L; Ródenas-Herranz T; Molina-Leyva A; Ruiz-Villaverde R
    Photodermatol Photoimmunol Photomed; 2022 Jul; 38(4):334-342. PubMed ID: 34773302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daylight Photodynamic Therapy for Actinic Keratoses.
    Morton CA; Braathen LR
    Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of occlusive vs non-occlusive application of 5-aminolevulinic acid (BF-200 ALA) on the efficacy and tolerability of photodynamic therapy for actinic keratosis on the scalp and face: A prospective within-patient comparison trial.
    Meierhofer C; Silic K; Urban MV; Tanew A; Radakovic S
    Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):56-62. PubMed ID: 32974974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
    Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential treatment with calcitriol and methyl aminolevulinate-daylight photodynamic therapy for patients with multiple actinic keratoses of the upper extremities.
    Piaserico S; Piccioni A; Gutiérrez Garcìa-Rodrigo C; Sacco G; Pellegrini C; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102325. PubMed ID: 33965603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face - protocol of a multicenter, prospective, randomized, controlled, two-armed study.
    Kohl E; Koller M; Zeman F; Szeimies RM; Philipp-Dormston WG; Prager W; Gerber PA; Karrer S
    BMC Dermatol; 2017 Oct; 17(1):12. PubMed ID: 29070025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of actinic keratosis on the hands with red light photodynamic therapy using BF-200 ALA.
    Ulrich M; Reinhold U; Dominicus R; Aschoff R; Szeimies RM; Schäning R; Zeuner MT; Pospiech N; Dirschka T
    Photodiagnosis Photodyn Ther; 2024 Oct; 49():104280. PubMed ID: 39002836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.